Carcinoma, Squamous Cell: all 1,779 studies
Page 16 of 18. Open to participants first (409), then studies with results posted, then the rest; newest registration first within each.
- Oral Rigosertib for Squamous Cell CarcinomaCompletedNCT01807546Phase 2
- BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line ChemotherapyTerminatedNCT01806649Phase 2
- Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal CarcinomaCompletedNCT01783158
- Set-back Suture Versus Traditional Vertical Mattress SutureCompletedNCT01773447Not applicable
- CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENTStatus unknownNCT01760811Phase 1/2
- Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of MalignanciesTerminatedNCT01755650Early Phase 1
- Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous CarcinomaStatus unknownNCT01752205Phase 3
- Role of Esophagectomy in Complete Responders to CCRTTerminatedNCT01740375Phase 3
- Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and NeckCompletedNCT01737008Phase 1
- Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWithdrawnNCT01728480Phase 1
- Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the PenisCompletedNCT01728233Phase 2
- Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC)CompletedNCT01721525Phase 1
- A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent ChemoradiotherapyTerminatedNCT01720563Phase 2
- Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal CancerWithdrawnNCT01718223Not applicable
- Pazopanib Plus Cetuximab for Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT01716416Phase 1
- Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical CancerCompletedNCT01711515Phase 1
- Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01695122Phase 2
- Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck CancerCompletedNCT01689194Phase 2
- Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)Active, not recruitingNCT01688908Not applicable
- Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT01688700Phase 2
- Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapyWithdrawnNCT01674374Phase 2
- Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib TreatmentTerminatedNCT01666431Phase 2
- Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and BrachytherapyCompletedNCT01663753Not applicable
- Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local ApplicationCompletedNCT01639625Phase 2
- Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
- Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral CavityCompletedNCT01636544Not applicable
- Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell CancerTerminatedNCT01627379Phase 3
- A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of EsophagusCompletedNCT01608022Phase 2
- A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.TerminatedNCT01606566Phase 2
- A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerCompletedNCT01598077Phase 1
- A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal CarcinomaCompletedNCT01591135Phase 3
- A Phase II Randomized Trial for Early-stage Squamous Cell Carcinoma of the Oropharynx: Radiotherapy vs Trans-oral Robotic Surgery (ORATOR)Status unknownNCT01590355Phase 2
- Developing an In-vitro Diagnostic Risk-Stratification Test for Oral CancerStatus unknownNCT01587573
- Stereotactic Boost for Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT01586182Phase 1/2
- A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And NeckCompletedNCT01577173Phase 2
- Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the LungCompletedNCT01561456Phase 2
- Involved Field Irradiation (IFI) Versus Elective Nodal Irradiation (ENI) for Esophageal CancerCompletedNCT01551589Not applicable
- TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell CarcinomaCompletedNCT01542931Phase 2/3
- Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E HistologyCompletedNCT01540695
- Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01538381Phase 2
- Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01528163Phase 2
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck CancerTerminatedNCT01528137Phase 1
- Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01527877Phase 2
- Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) TrialActive, not recruitingNCT01512589Phase 2
- IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01507467Phase 3
- Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer SurvivorsCompletedNCT01504932Not applicable
- Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell CarcinomaCompletedNCT01500954
- Genome-wide Association StudyWithdrawnNCT01498757
- A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line TreatmentStatus unknownNCT01497041Phase 2
- Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea PolyphenolsStatus unknownNCT01496521Phase 3
- Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerStatus unknownNCT01494415Phase 2
- Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and NeckWithdrawnNCT01491139Phase 1
- A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT01484847Not applicable
- Method Development and Assessment of the Effects of Tobacco Products on Oral Cavity CellsWithdrawnNCT01484769
- Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell CarcinomaCompletedNCT01474642Phase 2
- Prognostic Factor Analysis in Metastatic Esophageal Squamous Cell CarcinomaCompletedNCT01472419
- Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell CancerCompletedNCT01469598Phase 2
- Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.CompletedNCT01469429Phase 1/2
- Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell CarcinomaStatus unknownNCT01467921Phase 2
- Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)WithdrawnNCT01465815Phase 1/2
- Freeze-Dried Black Raspberries in Treating Patients With Oral Squamous Cell Cancer Undergoing SurgeryCompletedNCT01465776Not applicable
- PF-00299804 in Patients With Head and Neck Squamous Cell CarcinomaCompletedNCT01449201Phase 2
- Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNCT01445405Phase 1
- -02341066 and PF-00299804 for Advanced Non-Small Cell Lung CancerTerminatedNCT01441128Phase 1
- Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and NeckCompletedNCT01427478Phase 3
- Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)WithdrawnNCT01427205Phase 2
- Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell CarcinomaCompletedNCT01425736Phase 2
- Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC PatientsCompletedNCT01415674Phase 2
- Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After EsophagectomyStatus unknownNCT01402180Phase 2/3
- Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0Status unknownNCT01398449Phase 3
- A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal CancerStatus unknownNCT01391572Phase 2
- Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell CancerCompletedNCT01384708Early Phase 1
- Cabazitaxel - PF Induction ChemotherapyCompletedNCT01379339Phase 1
- Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaStatus unknownNCT01377298Phase 2
- Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive TractStatus unknownNCT01361100Not applicable
- EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01360827Phase 1
- Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to TherapyCompletedNCT01358097
- A Study of LGK974 in Patients With Malignancies Dependent on Wnt LigandsCompletedNCT01351103Phase 1
- Comparison of Adaptive Dose Painting by Numbers With Standard Radiotherapy for Head and Neck Cancer.CompletedNCT01341535Phase 2
- Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell CancerStatus unknownNCT01336049Phase 2
- Survival Benefit of Elective Neck Dissection in T1,2N0M0 Oral Squamous Cell CarcinomaStatus unknownNCT01334320Not applicable
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and NeckCompletedNCT01334177Phase 1
- Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck CancerTerminatedNCT01333852Phase 2
- Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and NeckStatus unknownNCT01333696Phase 2
- Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWithdrawnNCT01332279Phase 1
- Ex Vivo Multimodal Imaging of Upper Aerodigestive EpitheliumCompletedNCT01321892
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerCompletedNCT01316757Phase 2
- A Trial of Perioperative Immune Enhancing Feed in Patients Undergoing Surgery for Head and Neck CancerCompletedNCT01314755Not applicable
- A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and NeckTerminatedNCT01303237
- Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and NeckStatus unknownNCT01301248Phase 2
- Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical CancerStatus unknownNCT01295502Phase 1
- Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell CarcinomaStatus unknownNCT01291095Phase 2
- Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective NeckCompletedNCT01287390Phase 2
- Vectibix for the Treatment of Anal CancerCompletedNCT01285778Phase 2
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCCTerminatedNCT01283178Phase 1
- Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT01281852Phase 1
- Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and NeckCompletedNCT01275183Early Phase 1
- Comparison of Translocator Protein Expression and Binding Activity in Normal Tissue Versus Non Melanotic MalignancyStatus unknownNCT01265472
- Radio-chemotherapy With or Without Panitumumab (Vectibix®) in Irresectable Squamous Cell Carcinoma or Adenocarcinoma of the OesophagusTerminatedNCT01262183Phase 2
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2